Concurrent Administration of an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor and Cytotoxic Anticancer Drug to Treat Epidermal Growth Factor Receptor Gene Mutation-positive and Mutation-negative Lung Cancers